Tevimbra is under clinical development by BeiGene and currently in Phase II for Primary Mediastinal B-Cell Lymphoma.
Venetoclax is under clinical development by AbbVie and currently in Phase I for Primary Mediastinal B-Cell Lymphoma.
X-ray examination has certain limitations therefore, CT scanning should be the most important imaging method for diagnosing this disease. Overall, EMH needs to be differentiated from other conditions ...
The event Reddy referred to is a hypothetical phenomenon called Kessler Syndrome. Named for American astrophysicist Donald Kessler and based on his 1978 academic paper, Kessler Syndrome — as the ...
But for a small number of children, the infection triggers strange behavior changes known as PANDAS syndrome. PANDAS stands for Pediatric Autoimmune Neuropsychiatric Disorders Associated with ...
Conclusion: Radiotherapy volume size reduction from IFRT to INRT after ABVD chemotherapy for four cycles produces similar results and less toxicity in patients with early-stage Hodgkin’s lymphoma ...
Mediastinal lymphadenopathy is the medical ... with 61.6% having some form of this disease. The potential causes of swollen lymph nodes in the chest include: Except for the lymph nodes above ...
Intrathoracic goiter was first described by Haller in 1749 [ 1 ]. It can be primary or secondary. The primary type, also ...
AI-Enabled Analysis of Images Meant to Catch One Disease Can Reveal Others Dec. 4, 2024 — With the help of an AI tool, computed tomography (CT) scans taken originally to look for tumors or ...
COVID-19, caused by the single-stranded RNA virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted ...
Diagnosis Superior vena cava syndrome due to thrombotic obstruction---a complication of a cardiac procedure. Management Anticoagulation, catheter-directed thrombolytic therapy, mechanical ...
Experts from the World Health Organization provided an update on Sunday about the Disease X outbreak occurring in the Democratic Republic of the Congo. Although the report presents a more detailed ...